Cargando…
Receptor-interacting protein 1 kinase inhibition therapeutically ameliorates experimental T cell-dependent colitis in mice
Autores principales: | Gobbetti, Thomas, Berger, Scott B., Fountain, Kathryn, Slocombe, Tom, Rowles, Alison, Pearse, Gail, Harada, Isobel, Bertin, John, Haynes, Andrea C., Beal, Allison M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136199/ https://www.ncbi.nlm.nih.gov/pubmed/32249785 http://dx.doi.org/10.1038/s41419-020-2423-2 |
Ejemplares similares
-
How the humanities can ameliorate China's health-care crisis
por: Fan, Angela P, et al.
Publicado: (2020) -
Acute severe ulcerative colitis: confronting an intensified stressor during the COVID-19 pandemic
por: Shen, Bo
Publicado: (2021) -
Dimerization in protein kinase signaling
por: Pelech, Steven
Publicado: (2006) -
SARS-CoV-2 and HIV-1 — a tale of two vaccines
por: Haynes, Barton F.
Publicado: (2021) -
Improved ocular gene transfer with a Neddylation-site modified AAV-RPE65 vector in rd12 mice
por: Maurya, Shubham, et al.
Publicado: (2020)